PARK DENTAL PARTNERS INC (PARK)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$20.43-0.29%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
Intact: The reason to own it still holds.
Park Dental Partners keeps its revenue near $256 million in 2026. Earnings per share rise to about $1.52 this year. The company trades at a low price-to-earnings ratio of 6.03, much cheaper than peers at 21.49. It shows steady growth and strong business support for dentists.
Revenue growth could stall below $254 million. Earnings per share might fail to reach $1.50. The company faces elevated risk and may struggle to maintain its current profit margins.
The market price is about 47% below our valuation level, reflecting skepticism on growth. Our view expects the company to meet its revenue and earnings targets, which the market may be undervaluing.
Breaks if: EPS falls below $1.50 in FY26
Breaks if: Other revenue falls below $21 million in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a stable growth opportunity with a focus on acquisitions and geographic expansion. The current thesis state is mixed, reflecting both recent positive earnings and concerns about future guidance and economic conditions.
The market appears to price PARK as relatively cheap compared to peers, with a notable expectations gap. This suggests that investors may not fully account for potential growth from acquisitions and revenue increases.
Management has shown a commitment to maintaining revenue outlook and expanding capacity, which supports a positive growth trajectory. However, recent changes in company momentum and composite insight indicate some uncertainty in performance.
The thesis hinges on management's ability to meet revenue guidance and successfully execute acquisitions. Additionally, broader economic indicators, such as job growth and performance of sector leaders, will significantly influence PARK's outlook.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified at this time.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
The company is committed to maintaining its fiscal 2026 other revenue outlook range of $21M to $23M.
Breaks if: Annual revenue falls below $254 million in FY26
Continue to achieve revenue growth consistent with the 2026 full-year guidance range of $256M to $260M.
Stated as a priority in 3 of last 3 quarters. Revenue grew from $122.0 million in first half 2025 to $128.9 million in first half 2026, a 5.6% increase. Management has maintained the fiscal 2026 revenue outlook range at $256 million to $260 million, reflecting confidence in patient demand and acquisitions. The trajectory is delivering consistent revenue growth aligned with guidance.
“We are updating our full-year 2026 outlook to $256.0 – $260.0 million revenue.”
“We are maintaining our fiscal 2026 outlook range of $254.0 – $258.0 million revenue.”
“We are providing the following outlook for the full year ending December 31, 2026.”
Breaks if: P/E ratio rises above 15, reducing valuation advantage
Over the next 1 to 3 years, PARK's performance will depend on its execution of growth strategies and external economic factors. Not investment advice.